orlistat and Leukemia--T-Cell

orlistat has been researched along with Leukemia--T-Cell* in 1 studies

Other Studies

1 other study(ies) available for orlistat and Leukemia--T-Cell

ArticleYear
Fatty acid synthase inhibitor orlistat impairs cell growth and down-regulates PD-L1 expression of a human T-cell leukemia line.
    Journal of chemotherapy (Florence, Italy), 2020, Volume: 32, Issue:1

    Fatty Acid Synthase (FASN) is responsible for the

    Topics: B7-H1 Antigen; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Fatty Acid Synthase, Type I; Humans; Jurkat Cells; Leukemia, T-Cell; Orlistat

2020